Open | - |
Close | - |
Volume / Avg. | 13.971K / 596.416K |
Day Range | - - - |
52 Wk Range | 6.600 - 14.370 |
Market Cap | $448.007M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 2.78% |
Days to Cover | 3.24 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Health Catalyst (NASDAQ: HCAT) through any online brokerage.
Other companies in Health Catalyst’s space includes: MultiPlan (NYSE:MPLN), GoodRx Holdings (NASDAQ:GDRX), OptimizeRx (NASDAQ:OPRX), Definitive Healthcare (NASDAQ:DH) and TruBridge (NASDAQ:TBRG).
The latest price target for Health Catalyst (NASDAQ: HCAT) was reported by Cantor Fitzgerald on Tuesday, March 5, 2024. The analyst firm set a price target for 16.00 expecting HCAT to rise to within 12 months (a possible 109.15% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Health Catalyst (NASDAQ: HCAT) is $7.65 last updated Today at March 19, 2024 at 9:33 AM EDT.
There are no upcoming dividends for Health Catalyst.
Health Catalyst’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Health Catalyst.
Health Catalyst is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.